Published in J Clin Microbiol on February 01, 1984
Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses. J Clin Microbiol (1987) 3.54
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. J Virol (1985) 2.81
Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol (1985) 2.47
Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol (1986) 2.42
Genetic analysis of a human rotavirus that belongs to subgroup I but has an RNA pattern typical of subgroup II human rotaviruses. J Clin Microbiol (1987) 1.65
Relative frequencies of rotavirus serotypes 1, 2, 3, and 4 in Venezuelan infants with gastroenteritis. J Clin Microbiol (1988) 1.58
Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. J Clin Microbiol (1989) 1.28
Human viral gastroenteritis. Clin Microbiol Rev (1989) 1.21
Direct identification of serotypes of natural human rotavirus isolates by hybridization using cDNA probes derived from segment 9 of the rotavirus genome. J Clin Microbiol (1989) 1.13
Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus. J Clin Microbiol (1987) 1.06
Comparative sensitivities of solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for serotyping of human rotavirus strains with neutralizing monoclonal antibodies. J Clin Microbiol (1988) 1.05
Isolation of a human rotavirus strain with a super-short RNA pattern and a new P2 subtype. J Clin Microbiol (1999) 1.03
Genetic relatedness among human rotavirus genes coding for VP7, a major neutralization protein, and its application to serotype identification. J Clin Microbiol (1987) 1.03
Single-step antibody-based affinity cryo-electron microscopy for imaging and structural analysis of macromolecular assemblies. J Struct Biol (2014) 0.91
Identification of serotype 9 human rotavirus by enzyme-linked immunosorbent assay with monoclonal antibodies. J Clin Microbiol (1989) 0.87
Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes. J Clin Microbiol (2007) 0.87
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
Molecular epidemiology of human rotaviruses in Melbourne, Australia, from 1973 to 1979, as determined by electrophoresis of genome ribonucleic acid. J Clin Microbiol (1981) 4.23
Serological relationships between rotaviruses from different species as studied by complement fixation and neutralization. Arch Virol (1977) 4.19
Comparison of human and animal rotavirus strains by gel electrophoresis of viral RNA. Virology (1978) 4.08
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Isolation of human rotavirus in cell cultures: brief report. Arch Virol (1981) 3.83
Different serotypes of human rotaviruses. Lancet (1978) 3.74
Sequential passages of human rotavirus in MA-104 cells. Microbiol Immunol (1981) 3.73
Rotavirus serotypes by serum neutralisation. J Med Virol (1980) 3.65
Viral gastroenteritis. N Engl J Med (1981) 3.51
Shift in the prevalent human rotavirus detected by ribonucleic acid segment differences. Infect Immun (1980) 3.34
Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children. J Clin Microbiol (1981) 3.05
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Antigenic relationships among five reovirus-like (RVL) agents by complement fixation (CF) and development of new substitute CF antigens for the human RVL agent of infantile gastroenteritis. Proc Soc Exp Biol Med (1976) 2.74
Serotyping and subgrouping of rotavirus strains by the ELISA test. Arch Virol (1982) 2.49
Three human rotavirus serotypes demonstrated by plaque neutralization of isolated strains. Infect Immun (1982) 2.12
Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol (1982) 1.65
Enzyme-linked immunosorbent assays adapted for serotyping of human rotavirus strains. J Clin Microbiol (1980) 1.55
Human rotavirus serotypes. Lancet (1981) 1.29
Detection of rotavirus by serological trapping on antibody-coated electron microscope grids. J Clin Microbiol (1980) 1.25
Prevalence of subgroup 1, 2, and 3 rotaviruses in Belgian children suffering from acute diarrhea (1978-1981). J Med Virol (1983) 1.24
Solid-phase immune electron microscopy (SPIEM) by use of protein A and its application for characterization of selected adenovirus serotypes. J Med Virol (1982) 1.17
Comparison of immunosorbent electron microscopy, enzyme immunoassay and counterimmunoelectrophoresis for detection of human rotavirus in stools. J Virol Methods (1981) 1.12
Grouping of human adenoviruses by early antigen reactivity. J Infect Dis (1982) 0.92
Comparison of solid-phase immune electron microscopy, direct electron microscopy and enzyme-linked immunosorbent assay for detection of rotavirus in faecal samples. J Virol Methods (1982) 0.85
Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol (1992) 3.58
Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J Infect Dis (1991) 3.42
Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol (1990) 2.78
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. AIDS (1990) 2.15
Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients. J Med Virol (1989) 2.11
Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J Infect Dis (1992) 1.81
Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. J Virol Methods (1993) 1.75
In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J Gen Virol (2001) 1.74
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol (1995) 1.71
Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest (1993) 1.64
Correlation between immunofluorescent detection of human cytomegalovirus immediate early antigens in polymorphonuclear leukocytes and viremia. J Infect Dis (1989) 1.59
Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. J Gen Virol (1992) 1.53
Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol (2000) 1.53
Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis (1998) 1.51
Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis (1989) 1.47
Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. J Clin Virol (2009) 1.47
Serotyping of cell culture-adapted subgroup 2 human rotavirus strains by neutralization. Infect Immun (1984) 1.46
Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group. Antimicrob Agents Chemother (1994) 1.41
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. J Clin Invest (1998) 1.39
Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antiviral Res (1992) 1.38
Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients. J Clin Microbiol (1992) 1.36
Immunoglobulin G to virus-specific early antigens in congenital, primary, and reactivated human cytomegalovirus infections. Infect Immun (1978) 1.34
Distribution of VP4 gene alleles in human rotaviruses by using probes to the hyperdivergent region of the VP4 gene. J Clin Microbiol (1993) 1.30
The immunoperoxidase technique for rapid human cytomegalovirus identification. Arch Virol (1976) 1.28
Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol (1999) 1.25
High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol (2000) 1.24
Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein. J Virol Methods (1991) 1.23
Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection. J Med Virol (1995) 1.21
Characterization of serotypes of human rotavirus strains by solid-phase immune electron microscopy. J Infect Dis (1985) 1.20
Electropherotype heterogeneity within serotypes of human rotavirus strains circulating in Italy. Brief report. Arch Virol (1987) 1.18
Prenatal diagnosis of rubella virus infection by direct detection and semiquantitation of viral RNA in clinical samples by reverse transcription-PCR. J Clin Microbiol (1997) 1.14
The Cys607-->Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients. Antimicrob Agents Chemother (1998) 1.11
Antigenic and biological relationships between human coronavirus OC43 and neonatal calf diarrhoea coronavirus. J Gen Virol (1981) 1.11
Determination of neutralizing antibody and IgG antibody to varicella-zoster virus and of IgG antibody to membrane antigens by the immunoperoxidase technique. J Infect Dis (1977) 1.10
Characterization of unusual G8 rotavirus strains isolated from Egyptian children. Arch Virol (1999) 1.10
Immunoperoxidase technique for detection of antibodies to human cytomegalovirus. J Clin Microbiol (1976) 1.09
Correlation of viral load as determined by real-time RT-PCR and clinical characteristics of respiratory syncytial virus lower respiratory tract infections in early infancy. J Clin Virol (2007) 1.09
Quantitation of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis by the polymerase chain reaction. Clin Diagn Virol (1997) 1.08
Electropherotypes, subgroups and serotypes of human rotavirus strains causing gastroenteritis in infants and young children in Palermo, Italy, from 1985 to 1989. Res Virol (1991) 1.07
Association of BK virus with human brain tumors and tumors of pancreatic islets. Int J Cancer (1987) 1.06
Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients. J Med Virol (1995) 1.06
Rapid detection of human cytomegalovirus and herpesvirus hominis IgM antibody by the immunoperoxidase technique. Intervirology (1977) 1.06
Antibody to early antigens of varicella-zoster virus during varicella and zoster. J Infect Dis (1979) 1.05
Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients. J Med Virol (2001) 1.04
Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples. J Clin Microbiol (1995) 1.04
Isolation of an avianlike group A rotavirus from a calf with diarrhea. J Clin Microbiol (1992) 1.03
Human cytomegalovirus pp65 lower matrix phosphoprotein harbours two transplantable nuclear localization signals. J Gen Virol (1996) 1.01
HCV genotyping by three methods: analysis of discordant results based on sequencing. J Clin Virol (1999) 1.01
Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients. Br J Haematol (1995) 1.01
Human and bovine serotype G8 rotaviruses may be derived by reassortment. Arch Virol (1992) 1.01
Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates. Arch Virol (2005) 1.01
Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation (1995) 0.99
Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses. J Clin Microbiol (1999) 0.99
Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus. J Virol (1990) 0.99
Comparative evaluation of a commercial enzyme-linked immunoassay and solid-phase immune electron microscopy for rotavirus detection in stool specimens. J Clin Microbiol (1987) 0.99
Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. Transplantation (1998) 0.98
Serodiagnosis of respiratory synctial virus infections in infants and young children by the immunoperoxidse technique. J Clin Microbiol (1980) 0.96
Search for Coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol (1992) 0.95
Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction. J Med Virol (1998) 0.95
Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns. J Infect Dis (2001) 0.95
Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. J Clin Microbiol (1998) 0.94
Type specificity and use of human sera for rapid typing of herpes simplex virus isolates by an indirect peroxidase-labeled antibody technique: a comparison with three other methods. Arch Virol (1977) 0.94
Synergistic neutralization of rubella virus by monoclonal antibodies to viral haemagglutinin. J Gen Virol (1987) 0.94
Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia. Mol Cell Probes (1991) 0.94
Amino acids involved in distinguishing between monotypes of rotavirus G serotypes 2 and 4. J Gen Virol (1996) 0.94
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. Br J Haematol (1999) 0.93
The outer capsid glycoprotein VP7 of simian rotavirus SA11 contains two distinct neutralization epitopes. J Gen Virol (1988) 0.93
Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients. Am J Transplant (2007) 0.93
Grouping of human adenoviruses by early antigen reactivity. J Infect Dis (1982) 0.92
Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. AIDS Res Hum Retroviruses (1998) 0.92
Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein. J Virol (1999) 0.92
HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes. J Immunol (1993) 0.92
Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection. J Clin Microbiol (1998) 0.90
Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. Blood (1998) 0.90
A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates. Virus Res (1992) 0.90
Solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for typing of human rotavirus strains by using polyclonal and monoclonal antibodies: a comparative study. J Infect Dis (1989) 0.89
Identification of human cytomegalovirus isolates by the polymerase chain reaction. Microbiologica (1990) 0.89
Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetuses. J Infect Dis (1999) 0.89